Clever Leaves Inc. (CLVR)
0.00
-0.00 (-100.00%)
At close: Feb 26, 2025, 2:45 PM
2.40
199900.00%
Pre-market: Jul 05, 2024, 09:30 AM EDT
Clever Leaves Inc. Revenue Breakdown
| Quarter | Dec 31, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cannabinoid Revenue | 3.46M | 1.87M | 1.22M | 1.85M | 2.33M | 3.36M | 1.99M | 1.08M | 901K | 579K | 677K |
| Cannabinoid Revenue Growth | +84.89% | +53.27% | -33.95% | -20.46% | -30.73% | +68.41% | +83.78% | +20.42% | +55.61% | -14.48% | n/a |
| Non-Cannabinoid Revenue | 5M | 3.11M | 2.76M | 2.76M | 979K | 1.3M | 3.23M | 3.11M | 3.13M | 3.09M | 2.8M |
| Non-Cannabinoid Revenue Growth | +60.71% | +12.77% | -0.29% | +182.33% | -24.63% | -59.78% | +3.89% | -0.67% | +1.20% | +10.46% | n/a |
Revenue by Geography
| Quarter | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|
| Australia Revenue | 1.68M | 1.83M |
| Australia Revenue Growth | -8.28% | n/a |
| Brazil Revenue | 3.1M | 1.43M |
| Brazil Revenue Growth | +116.56% | n/a |
| Germany Revenue | 235K | 1.43M |
| Germany Revenue Growth | -83.58% | n/a |
| Israel Revenue | 600K | 1.42M |
| Israel Revenue Growth | -57.87% | n/a |
| Other Countries, Not Separately Disclosed Revenue | 941K | 218K |
| Other Countries, Not Separately Disclosed Revenue Growth | +331.65% | n/a |
| United States Revenue | 10.86M | 11.46M |
| United States Revenue Growth | -5.25% | n/a |
Operating Expense Breakdown
| Quarter | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 4.1M | 4.74M | 5.29M | 5.92M | 5.28M | 6.06M | 7.17M | 8.99M | 9.48M | 11.88M | 11.41M | 9.42M | 8.99M | 6.25M | 7.87M | 9.3M | 18.04M | 9.64M | 5.65M | 4.21M |
| Selling, General, and Administrative Revenue Growth | -13.41% | -10.54% | -10.50% | +12.15% | -12.91% | -15.53% | -20.27% | -5.12% | -20.22% | +4.11% | +21.16% | +4.82% | +43.79% | -20.55% | -15.42% | -48.45% | +87.12% | +70.64% | +34.26% | n/a |
| Research and Development Revenue | 233K | 292K | 403K | 212K | 605K | 343K | 359K | 412K | 1.55M | 454K | 305K | 278K | 1.01M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | -20.21% | -27.54% | +90.09% | -64.96% | +76.38% | -4.46% | -12.86% | -73.35% | +240.53% | +48.85% | +9.71% | -72.45% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales and Marketing Revenue | 436K | 582K | 469K | 549K | -179K | 615K | 728K | 733K | 1.5M | 812K | 807K | 678K | 285K | 508K | 603K | 1.18M | 1.27M | 1.72M | 10K | 183K |
| Sales and Marketing Revenue Growth | -25.09% | +24.09% | -14.57% | -406.70% | -129.11% | -15.52% | -0.68% | -51.10% | +84.61% | +0.62% | +19.03% | +137.89% | -43.90% | -15.75% | -48.94% | -7.30% | -25.76% | +17060.00% | -94.54% | n/a |